This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
National Association of SpecialtyPharmacy (NASP) 2022 Annual Meeting & Expo. September 19-22, 2022 | Gaylord Palms Resort & Convention Center | Orlando, FL. The National Association of SpecialtyPharmacy (NASP) will host the NASP 2022 Annual Meeting & Expo September 19-22.
Two weeks ago, Paula and I had the pleasure of attending Asembia’s 2022SpecialtyPharmacy Summit at the wonderful Wynn Las Vegas. I offer reflections on my keynote session with Scott Gottlieb, share my experiences during the featured session, and highlight three crucial specialty industry trends.
This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. Click here to see the original post from May 2022. You will see that PBMs and insurers retained their dominance over specialty dispensing. d/b/a Drug Channels Institute.
It’s estimated specialty medications account for 75% of the approximately 7,000 prescription drugs currently in development, and by 2022, more than 60% of the 600 drugs expected to gain FDA approval will be specialty medications. Navigating the cost of specialty medications.
Informa Connect’s Hub and SpecialtyPharmacy Models East. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy. For 2022 only, Hub and SpecialtyPharmacy Models and PAP – Patient Assistance & Access Programs are under the same roof.
Next week, I'll be live and in-person at Asembia's SpecialtyPharmacy Summit. During Tuesday's general session, I'll be joining Dr. Scott Gottlieb for a fireside chat at 8:00 AM and will then present my "State of SpecialtyPharmacy2022" at 9:30 AM. Hope to see you there!
5, 2022) – Amber SpecialtyPharmacy is excited to announce that it is a partner of WeInfuse’s SpecialtyPharmacy Connect Program. Amber SpecialtyPharmacy provides personalized and reliable care to those with complex and chronic conditions with a dedicated team that can guide patients through this new process.
19, 2024) – Amber SpecialtyPharmacy announces the appointment of Jessica Ringena as its newest president. Ringena previously served as president of Vivid Clear Rx, a pharmacy benefit manager and subsidiary of Hy-Vee. The provider specializes in transplant, infusion and specialty care, including rare/orphan drugs and oncology.
Let’s turn up the heat with these sizzling news bites straight from the Drug Channels grill: SaveonSP gets sued Thoughts on the Medicaid accumulator rule opinion CVS buys AmerisourceBergen’s specialtypharmacy Fresh data on hospitals’ cancer drug profiteering Plus, Dr. Glaucomflecken explains Aetna’s prior authorization policies.
Today’s guest post comes from Megan Marchal, Director of SpecialtyPharmacy Strategy at CoverMyMeds. Megan discusses the access and affordability challenges faced by specialty therapy patients. Click here to sign up for CoverMyMeds’ Asembia SpecialtyPharmacy Summit recaps. Read on for Megan’s insights.
prescription dispensing revenues for calendar year 2022. prescription dispensing revenues reached a record $548 billion in 2022. The largest 15 pharmacies accounted for more than 75% of total dispensing revenues from retail, mail, long-term care, and specialtypharmacies.
340B ESP and drug manufacturer restrictions are only part of the reason As we noted in a previous post , for 340B-eligible hospitals dealing with increasingly squeezed bottom lines, an in-house specialtypharmacy offers enormous savings and revenue potential. We published that post in September, 2022.
In this issue: The State of SpecialtyPharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble Reconsidering Amazon P.S. Please join the nearly 13,000 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter. Happy Thanksgiving, everyone!
3, 2022) – Amber SpecialtyPharmacy announces today that they will begin dispensing 13 Pfizer oncology products. The pharmacy’s comprehensive service model will support patients, caregivers, and oncology specialists throughout the country. For more information about Amber SpecialtyPharmacy, call (888) 370-1724.
I am pleased to announce our new 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Prescription Market (press release) We’re offering special discounted pricing if you order before March 28, 2022. The 2022 Economic Report on U.S.
Please join me for my upcoming live video webinar, Drug Channels Outlook 2022 , on December 17, 2021, from 12:00 p.m. Happy Thanksgiving, everyone! Before you stretch your stomach, stretch your mind with our extra-stuffed helping of food for thought. to 1:30 p.m. Will you be there, too? d/b/a Drug Channels Institute.
ELK GROVE VILLAGE, IL – August 2023 – Orsini SpecialtyPharmacy ("Orsini"), a leading independent specialtypharmacy focused on rare diseases and gene therapies, announced today that Darin DeCarlo has been named the company's first ever Chief Growth Officer.
In this issue: The State of SpecialtyPharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble CVS acknowledges how its PBM profits from 340B Reconsidering Amazon Plus, the FDA preps you for Thursday with a regulatory soup review. Happy Thanksgiving, everyone! to 1:30 p.m.
Why a SpecialtyPharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
Why a SpecialtyPharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2022. The Outlook 2022 marks our third annual outlook webinar. Broadcast live on December 17, 2021. to 1:30 p.m.
Broadcast live on April 22, 2022 , from 12:00 p.m. This event is part of The Drug Channels 2022 Video Webinar Series. Fein as he helps you and your team stay on top of the latest trends, market data, and strategies for pharmacy benefit management. Pharmacies and Pharmacy Benefit Managers. to 1:30 p.m.
Stacey discusses digital hubs and the affordability advantages they offer both patients on specialty therapies and their health care providers. To learn more, click here to schedule a meeting with AssistRx at Asembia’s SpecialtyPharmacy Summit on April 30 to May 4, 2023. Read on for Stacey’s insights.
21, 2022) – Amber SpecialtyPharmacy announces that it will begin dispensing TZIELD (teplizumab), an anti-CD3 monoclonal antibody, to delay Stage 3 Type 1 Diabetes (T1D) in patients ages 8 years and older with Stage 2 T1D. Read more about the pharmacy’s infusion service offerings here. OMAHA, Neb.
Why a SpecialtyPharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
Like it or not, vertically integrated insurers, PBMs, specialtypharmacies, and providers will continue to prosper. Nonetheless, taxpayersprimarily via Medicare and Medicaidwill continue to dominate the employer-sponsored insurance market. Read more 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.
As always, we have updated all market and industry data with the most current information available, including our annual analyses of the market positions of the largest pharmacies, specialtypharmacies, and PBMs. addresses the Inflation Reduction Act of 2022. A new Section 12.5. In Subsection 12.5.1.,
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content